Management of Suicidal Ideation in Young Adults

Immediate Pharmacological Management

The American Academy of Child and Adolescent Psychiatry recommends starting an SSRI, preferably fluoxetine or sertraline, immediately, with close monitoring for akathisia and behavioral activation during the first 2 weeks, while simultaneously initiating cognitive-behavioral therapy focused on suicide prevention 1, 2
All medication must be monitored and dispensed by a third party who can immediately report any behavioral changes, increased agitation, or new suicidal ideation 1, 2, 3
Assess for akathisia at every contact during the first 2 weeks, as this is a critical warning sign that may drive suicidal urges 3, 4
Systematically inquire about suicidal ideation before and after treatment initiation, distinguishing between passive ideation versus active planning with intent 2, 3

The American Academy of Child and Adolescent Psychiatry advises that tricyclic antidepressants must not be prescribed due to high lethality in overdose and lack of proven efficacy in young adults 1, 2, 5
Benzodiazepines should be avoided as they may cause disinhibition, reduce self-control, and potentially increase aggression or suicide attempts 1, 2, 4, 5

Cognitive-behavioral therapy focused on suicide prevention must be initiated immediately, as it reduces suicidal ideation and cuts suicide attempt risk by half compared to treatment as usual 1, 2, 5
Develop a safety planning intervention, which reduces suicidal behavior with a relative risk of 0.570 (number needed to treat = 16) 3

Explicitly instruct family to remove all firearms and lethal medications from the home environment 1, 5
Warn the patient and family about the dangerous disinhibiting effects of alcohol and other drugs 1

Ketamine infusion can be considered for rapid reduction of suicidal ideation if the patient remains acutely suicidal despite initial interventions, with effects beginning within 24 hours 2
If mood swings, manic symptoms, or rapid cycling develop, immediately add lithium or a mood stabilizer before continuing antidepressant therapy, as antidepressants without mood stabilizers may trigger manic episodes 2
Lithium has the strongest evidence for reducing suicide attempts (8.6-fold reduction) in bipolar disorder 2, 4

Do not rely on "no-suicide contracts" as their value is not established, and both family and clinician should not relax vigilance just because a contract has been signed 1, 5
Do not assume safety based on initial improvement - be particularly vigilant during the early stages of treatment when medication changes are made 2
Do not discharge without ensuring close follow-up - schedule an appointment before discharge or establish a procedure for clinical staff to initiate contact if the family does not follow up 1, 5